News
ACUR
0.0001
NaN%
--
Weekly Report: what happened at ACUR last week (0914-0918)?
Weekly Report · 20h ago
Weekly Report: what happened at ACUR last week (0907-0911)?
Weekly Report · 09/14 09:05
Weekly Report: what happened at ACUR last week (0831-0904)?
Weekly Report · 09/07 09:05
Weekly Report: what happened at ACUR last week (0824-0828)?
Weekly Report · 08/31 09:05
Acura Pharmaceuticals Discloses Major SEC Filing Delays
TipRanks · 08/26 14:20
Weekly Report: what happened at ACUR last week (0817-0821)?
Weekly Report · 08/24 09:05
Acura Pharmaceuticals Secures Loan Amid Going-Concern Risks
TipRanks · 08/20 19:48
Weekly Report: what happened at ACUR last week (0810-0814)?
Weekly Report · 08/17 09:05
Weekly Report: what happened at ACUR last week (0803-0807)?
Weekly Report · 08/10 09:05
Weekly Report: what happened at ACUR last week (0727-0731)?
Weekly Report · 08/03 09:05
Weekly Report: what happened at ACUR last week (0720-0724)?
Weekly Report · 07/27 09:05
Acura Pharmaceuticals Secures New Loan Amid Liquidity Strain
TipRanks · 07/24 20:53
Weekly Report: what happened at ACUR last week (0713-0717)?
Weekly Report · 07/20 09:05
Weekly Report: what happened at ACUR last week (0706-0710)?
Weekly Report · 07/13 09:05
Weekly Report: what happened at ACUR last week (0629-0703)?
Weekly Report · 07/06 09:05
Acura Pharmaceuticals Extends Maturity of Key Secured Note
TipRanks · 06/29 20:54
Weekly Report: what happened at ACUR last week (0622-0626)?
Weekly Report · 06/29 09:05
Weekly Report: what happened at ACUR last week (0615-0619)?
Weekly Report · 06/22 09:06
Weekly Report: what happened at ACUR last week (0608-0612)?
Weekly Report · 06/15 09:06
Weekly Report: what happened at ACUR last week (0601-0605)?
Weekly Report · 06/08 09:05
More
Webull provides a variety of real-time ACUR stock news. You can receive the latest news about Acura Pharm through multiple platforms. This information may help you make smarter investment decisions.
About ACUR
Acura Pharmaceuticals, Inc. is a drug delivery company engaged in the research, development, and commercialization of technologies and products to address the safe use of medications. Its platform technologies include LIMITX Technology, AVERSION Technology, and IMPEDE Technology. Its LIMITX Technology is designed to minimize the risks and side effects associated with overdose by retarding the release of active drug ingredients when too many tablets are accidentally or purposefully ingested. The LIMITX Technology is in development with hydrocodone bitartrate and acetaminophen (also known as LTX-03) as the lead product candidates. Its AVERSION Technology is to address methods of product tampering associated with opioid abuse by incorporating gelling ingredients and irritants into tablets to discourage abuse by snorting and provide barriers to abuse by injection. Its IMPEDE Technology is directed at minimizing the extraction and conversion of pseudoephedrine tablets into methamphetamine.